Skip to main content
PMC home page
British Heart Journal logoLink to British Heart Journal
. 1980 Sep;44(3):290–296. doi: 10.1136/hrt.44.3.290

Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.

A B Atkinson, J J Morton, J J Brown, D L Davies, R Fraser, P Kelly, B Leckie, A F Lever, J I Robertson
PMCID: PMC482400  PMID: 7000102

Abstract

The effect of the converting enzyme inhibitor captopril on arterial pressure, the components of the renin-angiotensin-aldosterone system, and body sodium and potassium content was studied in eight hypertensive patients with renal artery stenosis and, in conjunction with diuretics, in seven patients with hypertension unresponsive to previous treatment. Two hours after the first dose, captopril caused significant falls in systolic and diastolic pressures, plasma angiotensin II, and aldosterone, with converse increases in angiotensin I and both active and total renin; the initial fall in diastolic pressure was significantly related to the drop in plasma angiotensin II. The biochemical changes were sustained during prolonged treatment, even when diuretics were added. One untreated patient with renal artery occlusion had severe secondary aldosterone excess, was sodium and potassium depleted, and severely hyponatraemic and hypokalaemic; captopril restored blood pressure, plasma electrolyte concentrations, and exchangeable sodium and total body potassium to normal. In one man with renal artery stenosis and overall renal impairment captopril led to sodium retention, and blood pressure did not fall until a diuretic was added. In the remaining patients with renal artery stenosis, pretreatment renin, angio tensin II, and aldosterone concentrations were either normal or only modestly raised, and plasma electrolyte concentrations and body content of sodium and potassium were normal. Captopril alone controlled arterial pressure in all, three cases showing a gradual fall of pressure over the first six weeks of treatment; no significant changes in exchangeable sodium or total body potassium were seen. The group of patients with previously intractable hypertension were all controlled with a combination of captopril and diuretic.

Full text

PDF
290

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atkinson A. B., Brown J. J., Fraser R., Leckie B., Lever A. F., Morton J. J., Robertson J. I. Captopril in hypertension with renal artery stenosis and in intractable hypertension; acute and chronic changes in circulating concentrations of renin, angiotensins I and II and aldosterone, and in body composition. Clin Sci (Lond) 1979 Dec;57 (Suppl 5):139s–143s. doi: 10.1042/cs057139s. [DOI] [PubMed] [Google Scholar]
  2. Atkinson A. B., Brown J. J., Fraser R., Leckie B., Lever A. F., Morton J. J., Robertson J. I. Captopril, angiotensin II, and sodium in blood-pressure regulation. Lancet. 1979 May 26;1(8126):1140–1140. [PubMed] [Google Scholar]
  3. Atkinson A. B., Brown J. J., Fraser R., Lever A. F., Morton J. J., Riegger A. J., Robertson J. I. Angiotensin II and renal hypertension in dog, rat and man: effect of converting enzyme inhibition. Clin Exp Hypertens. 1980;2(3-4):499–524. doi: 10.3109/10641968009037127. [DOI] [PubMed] [Google Scholar]
  4. Atkinson A. B., Davies D. L., Leckie B., Morton J. J., Brown J. J., Fraser R., Lever A. F., Robertson J. I. Hyponatraemic hypertensive syndrome with renal-artery occlusion corrected by captopril. Lancet. 1979 Sep 22;2(8143):606–609. doi: 10.1016/s0140-6736(79)91666-0. [DOI] [PubMed] [Google Scholar]
  5. Atkinson A. B., Robertson J. I. Captopril in the treatment of clinical hypertension and cardiac failure. Lancet. 1979 Oct 20;2(8147):836–839. doi: 10.1016/s0140-6736(79)92186-x. [DOI] [PubMed] [Google Scholar]
  6. Atlas S. A., Case D. B., Sealey J. E., Laragh J. H., McKinstry D. N. Interruption of the renin-angiotensin system in hypertensive patients by captopril induces sustained reduction in aldosterone secretion, potassium retention and natruiresis. Hypertension. 1979 May-Jun;1(3):274–280. doi: 10.1161/01.hyp.1.3.274. [DOI] [PubMed] [Google Scholar]
  7. BAUER H., FORBES L. Unilateral renal artery obstruction associated with malignant nephrosclerosis confined to the opposite kidney. Am Heart J. 1952 Oct;44(4):634–638. doi: 10.1016/0002-8703(52)90204-4. [DOI] [PubMed] [Google Scholar]
  8. BROWN J. J., PEART W. S., OWEN K., ROBERTSON J. I., SUTTON D. The diagnosis and treatment of renal-artery stenosis. Br Med J. 1960 Jul 30;2(5195):327–338. doi: 10.1136/bmj.2.5195.327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Barraclough M. A. Sodium and water depletion with acute malignant hypertension. Am J Med. 1966 Feb;40(2):265–272. doi: 10.1016/0002-9343(66)90107-0. [DOI] [PubMed] [Google Scholar]
  10. Boddy K., Brown J. J., Davies D. L., Elliott A., Harvey I., Haywood J. K., Holloway I., Lever A. F., Robertson J. I., Williams E. D. Concurrent estimation of total body and exchangeable body sodium in hypertension. Clin Sci Mol Med. 1978 Feb;54(2):187–191. doi: 10.1042/cs0540187. [DOI] [PubMed] [Google Scholar]
  11. Boddy K., King P. C., Tothill P., Strong J. A. Measurement of total body potassium with a shadow shield whole-body counter: calibration and errors. Phys Med Biol. 1971 Apr;16(2):275–282. doi: 10.1088/0031-9155/16/2/310. [DOI] [PubMed] [Google Scholar]
  12. Bravo E. L., Tarazi R. C. Converting enzyme inhibition with an orally active compound in hypertensive man. Hypertension. 1979 Jan-Feb;1(1):39–46. doi: 10.1161/01.hyp.1.1.39. [DOI] [PubMed] [Google Scholar]
  13. Brown J. J., Lever A. F., Davies D. L., Robertson J. I. Renin and angiotensin. A survey of some aspects. Postgrad Med J. 1966 Mar;42(485):153–176. doi: 10.1136/pgmj.42.485.153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Brunner H. R., Gavras H., Waeber B., Kershaw G. R., Turini G. A., Vukovich R. A., McKinstry D. N., Gavras I. Oral angiotensin-converting enzyme inhibitor in long-term treatment of hypertensive patients. Ann Intern Med. 1979 Jan;90(1):19–23. doi: 10.7326/0003-4819-90-1-19. [DOI] [PubMed] [Google Scholar]
  15. Brunner H. R., Waeber B., Wauters J. P., Turin G., McKinstry D., Gavras H. Innappropriate renin secretion unmasked by captopril (SQ 14 225) in hypertension of chronic renal failure. Lancet. 1978 Sep 30;2(8092 Pt 1):704–707. doi: 10.1016/s0140-6736(78)92703-4. [DOI] [PubMed] [Google Scholar]
  16. Davies D. L., Beevers D. G., Briggs J. D., Medina A. M., Robertson J. I., Schalekamp M. A., Brown J. J., Lever A. F., Morton J. J., Tree M. Abnormal relation between exchangeable sodium and the renin-angiotensin system in malignant hypertension and in hypertension with chronic renal failure. Lancet. 1973 Mar 31;1(7805):683–686. doi: 10.1016/s0140-6736(73)91476-1. [DOI] [PubMed] [Google Scholar]
  17. Davies D. L., Robertson J. W. Simultaneous measurement of total exchangeable potassium and sodium using 43 K and 24 Na. Metabolism. 1973 Feb;22(2):133–137. doi: 10.1016/0026-0495(73)90263-1. [DOI] [PubMed] [Google Scholar]
  18. Johnston C. I., Millar J. A., McGrath B. P., Matthews P. G. Long-term effects of captopril (SQ14 225) on blood-pressure and hormone levels in essential hypertension. Lancet. 1979 Sep 8;2(8141):493–496. doi: 10.1016/s0140-6736(79)91552-6. [DOI] [PubMed] [Google Scholar]
  19. Marks E. S., Bing R. F., Thurston H., Swales J. D. Vasodepressor property of the converting enzyme inhibitor captopril (SQ 14 225): the role of factors other than renin-angiotensin blockade in the rat. Clin Sci (Lond) 1980 Jan;58(1):1–6. doi: 10.1042/cs0580001. [DOI] [PubMed] [Google Scholar]
  20. Riegger A. J., Lever A. F., Millar J. A., Morton J. J., Slack B. Correction of renal hypertension in the rat by prolonged infusion of angiotensin inhibitors. Lancet. 1977 Dec 24;2(8052-8053):1317–1319. doi: 10.1016/s0140-6736(77)90366-x. [DOI] [PubMed] [Google Scholar]
  21. Schalekamp M. A., Beevers D. G., Briggs J. D., Brown J. J., Davies D. L., Fraser R., Lebel M., Lever A. F., Medina A., Morton J. J. Hypertension in chronic renal failure. An abnormal relation between sodium and the renin-angiotensin system. Am J Med. 1973 Sep;55(3):379–390. doi: 10.1016/0002-9343(73)90137-x. [DOI] [PubMed] [Google Scholar]
  22. Semple P. F., Cumming A. M., Millar J. A. Angiotensins I and II in renal vein blood. Kidney Int. 1979 Mar;15(3):276–282. doi: 10.1038/ki.1979.35. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES